United Services Automobile Association Global Blood Therapeutics, Inc. Transaction History

United Services Automobile Association

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$45.35 - $57.91 $2.96 Million - $3.78 Million	-65,201 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$52.6 - $63.29 $45,393 - $54,619	863 Added 1.34%	65,201 $3.43 Million
Q4 2018 Feb 13, 2019	SELL	$31.54 - $46.67 $103,482 - $153,124	-3,281 Reduced 4.85%	64,338 $2.64 Million
Q3 2018 Nov 13, 2018	SELL	$38.0 - $51.1 $62,662 - $84,263	-1,649 Reduced 2.38%	67,619 $2.57 Million
Q2 2018 Aug 10, 2018	SELL	$38.7 - $50.15 $16,834 - $21,815	-435 Reduced 0.62%	69,268 $3.13 Million
Q1 2018 May 14, 2018	BUY	$39.6 - $65.9 $2.76 Million - $4.59 Million	69,703 New	69,703 $3.37 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.